Literature DB >> 24461762

Integrating real-life studies in the global therapeutic research framework.

Nicolas Roche1, Helen K Reddel2, Alvar Agusti3, Eric D Bateman4, Jerry A Krishnan5, Richard J Martin6, Alberto Papi7, Dirkje Postma8, Mike Thomas9, Guy Brusselle10, Elliot Israel11, Cynthia Rand12, Alison Chisholm13, David Price14.   

Abstract

Mesh：

Year:  2013        PMID： 24461762     DOI： 10.1016/S2213-2600(13)70199-1

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  40 in total

1.  Time to get real: critical and imperative change required in evidence evaluation.

Authors:  David B Price
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 2.  Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.

Authors:  Prescott G Woodruff; Alvar Agusti; Nicolas Roche; Dave Singh; Fernando J Martinez
Journal:  Lancet       Date:  2015-05-02       Impact factor: 79.321

3.  Implementation of the kidney team at home intervention: Evaluating generalizability, implementation process, and effects.

Authors:  Steef Redeker; Emma K Massey; Charlotte Boonstra; Jan J van Busschbach; Reinier Timman; Harald F H Brulez; Daan A A M J Hollander; Luuk B Hilbrands; Frederike Bemelman; Stefan P Berger; Jacqueline van de Wetering; René M A van den Dorpel; Margriet Dekker-Jansen; Willem Weimar; Sohal Y Ismail
Journal:  Transpl Int       Date:  2021-09-21       Impact factor: 3.842

Review 4.  Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.

Authors:  Federico Lavorini; Claudia Mannini; Elisa Chellini; Giovanni A Fontana
Journal:  Drugs Aging       Date:  2016-07       Impact factor: 3.923

Review 5.  Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease.

Authors:  Marc Miravitlles; David Price; Klaus F Rabe; Hendrik Schmidt; Norbert Metzdorf; Bartolome Celli
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-03-16

Review 6.  Long-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designs.

Authors:  Cynthia A Bossie; Larry D Alphs; Christoph U Correll
Journal:  Int Clin Psychopharmacol       Date:  2015-09       Impact factor: 1.659

Review 7.  A summary of the new GINA strategy: a roadmap to asthma control.

Authors:  Helen K Reddel; Eric D Bateman; Allan Becker; Louis-Philippe Boulet; Alvaro A Cruz; Jeffrey M Drazen; Tari Haahtela; Suzanne S Hurd; Hiromasa Inoue; Johan C de Jongste; Robert F Lemanske; Mark L Levy; Paul M O'Byrne; Pierluigi Paggiaro; Soren E Pedersen; Emilio Pizzichini; Manuel Soto-Quiroz; Stanley J Szefler; Gary W K Wong; J Mark FitzGerald
Journal:  Eur Respir J       Date:  2015-07-23       Impact factor: 16.671

8.  Clinical Outcome Predictive Value of Procalcitonin in Patients Suspected with Infection in the Emergency Department.

Authors:  Pierre Leroux; Sébastien De Ruffi; Laurent Ramont; Marion Gornet; Guillaume Giordano Orsini; Xavier Losset; Lukshe Kanagaratnam; Stéphane Gennai
Journal:  Emerg Med Int       Date:  2021-06-10       Impact factor: 1.112

Review 9.  Real-world research and its importance in respiratory medicine.

Authors:  David Price; Guy Brusselle; Nicolas Roche; Daryl Freeman; Alison Chisholm
Journal:  Breathe (Sheff)       Date:  2015-03

10.  A real - life observational pilot study to evaluate the effects of two-week treatment with montelukast in patients with chronic cough.

Authors:  Roxana K Mincheva; Tanya Z Kralimarkova; Miroslava Rasheva; Zlatko Dimitrov; Denislava Nedeva; Maria Staevska; Vera Papochieva; Penka Perenovska; Karina Bacheva; Vasil D Dimitrov; Todor A Popov
Journal:  Cough       Date:  2014-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.